{
  "id": 16943225,
  "title": "HHS to allow sale of unapproved peptides under review",
  "url": "https://urgent.news/2026/10/28/hhs-to-allow-sale-of-unapproved-peptides-under-review",
  "topic": "world",
  "section": "World",
  "published": "2026-10-28T18:18:27.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6178382-hhs-peptides-compounding-pharmacies-maha-agenda/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to those championed by the \"Make America Healthy Again\" (MAHA) agenda. The HHS stated in a notice that it would be practicing enforcement discretion...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}